Drug Delivery & Bio-Conjugation

This feed describes how bioconjugation, a covalent linking between the drug molecule and a biomolecule, can alter (facilitate or impede) drug delivery in living organisms. Discover the latest research on bioconjugation in drug delivery here

October 14, 2020
Open Access

Health outcomes and cost-effectiveness of diversion programs for low-level drug offenders: A model-based analysis

PLoS Medicine
Cora L BernardMargaret L Brandeau
October 14, 2020
Open Access

The role of drug treatment and recovery services: an opportunity to address injection initiation assistance in Tijuana, Mexico

Substance Abuse Treatment, Prevention, and Policy
Stephanie A MeyersMaria Luisa Mittal
October 14, 2020

A review of recent advances in nanodiamond-mediated drug delivery in cancer

Expert Opinion on Drug Delivery
E PerevedentsevaC-L Cheng
October 14, 2020

Microencapsulated Soil Conditioner with a Water-Soluble Core: Improving Soil Nutrition of Crop Root

Journal of Microencapsulation
Zuo WangShihui Liu
October 14, 2020

A mixed-methods approach to understanding overdose risk-management strategies among a nationwide convenience sample

The International Journal on Drug Policy
Grant A VictorChristopher Flaherty
October 13, 2020

Peptide hydrogel scaffold for mesenchymal precursor cells implanted to injured adult rat spinal cord

Tissue Engineering. Part a
Tylie WisemanStuart Ian Hodgetts
October 14, 2020
Open Access

Wide-spectrum cancer killing by ENDOD1 ablation

BioRxiv : the Preprint Server for Biology
Z. TangCong Liu
October 14, 2020

The regulation project: Tools for engaging the public in the legal regulation of drugs

The International Journal on Drug Policy
Scott E BernsteinDonald MacPherson
October 15, 2020
Open Access

Synaptosomes: New Vesicles for Neuronal Mitochondrial Transplantation

Pasquale PiconeMarta Di Carlo
October 14, 2020
Open Access

Chemotherapy response prediction with diffuser elapser network

BioRxiv : the Preprint Server for Biology
B. KoyuncuMehmet Burcin Unlu
October 13, 2020

Risks and complications associated with dental implant failure: Critical update

National Journal of Maxillofacial Surgery
Shubha Ranjan DuttaAbhimanyu Sharma
October 14, 2020

Nucleic Acid Biohybrid Nanocarriers with High Therapeutic Payload and Controllable Extended Release of Daunomycin for Cancer Therapy

Journal of Biomedical Materials Research. Part a
Ricky WhitenerMark E Byrne
October 13, 2020

Investigations on dose proportionality and drug-drug interaction for a fixed-dose combination of trazodone and gabapentin

International Journal of Clinical Pharmacology and Therapeutics
Alessandro RuggieriHenning H Blume
October 14, 2020

Radiolabeling strategies and pharmacokinetic studies for metal based nanotheranostics

Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology
Shahab Ranjbar BahadoriXiankai Sun

Sign up to follow this feed and discover related papers.

Related Feeds


Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.


Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.


Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.


An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

© 2020 Meta ULC. All rights reserved